Rotavirus vaccine will have an impact in Asia

Carl Kirkwood and Duncan Steele discuss the evidence supporting rotavirus vaccine deployment in Asian countries.

Vyšlo v časopise: Rotavirus vaccine will have an impact in Asia. PLoS Med 14(5): e32767. doi:10.1371/journal.pmed.1002298
Kategorie: Perspective
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1002298

Souhrn

Carl Kirkwood and Duncan Steele discuss the evidence supporting rotavirus vaccine deployment in Asian countries.

Zdroje

1. GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1659–724. doi: 10.1016/S0140-6736(16)31679-8 27733284

2. WHO. Meeting of the Immunization Strategic Advisory Group of Experts, April 2009. Conclusions and recommendations. Wkly Epidemiol Rec. 2009;84:517–32. 19999831

3. Nelson EAS, Widdowson MA, Kilgore PE, Steele D, Parashar UD. A decade of the Asian Rotavirus Surveillance Network: Achievements and future directions. Vaccine. 2009;27 suppl 5:F1–3.

4. Zaman K, Yunus M, Faruque AS, El Arifeen S, Hossain I, Azim T, et al. Surveillance of rotavirus in a rural diarrhoea treatment centre in Bangladesh: 2000–2006. Vaccine. 2009;27 suppl 5:F31–34.

5. Kollaritsch H, Kundi M, Giaquinto C, Paulke-Korinek M. Rotavirus vaccines: a story of success. Clin Microbiol Infect. 2015;21:735–43. doi: 10.1016/j.cmi.2015.01.027 25680314

6. Richardson V, Parashar U, Patel M. Childhood diarrhea deaths after rotavirus vaccination in Mexico. N Engl J Med. 2011;365:772–73. doi: 10.1056/NEJMc1100062 21864191

7. Bar-Zeev N, Kapanda L, Tate JE, Jere KC, Iturriza-Gomara M, Nakagomi O, et al. Effectiveness of a monovalent rotavirus vaccine in infants in Malawi after programmatic roll-out: An observational and case-control study. Lancet Infect Dis. 2015;15:422–28. doi: 10.1016/S1473-3099(14)71060-6 25638521

8. Tate JE, Ngabo F, Donnen P, Gatera M, Uwimana J, Rugambwa C, et al. Effectiveness of pentavalent vaccine under conditions of routine use in Rwanda. Clin Infect Dis. 2016;62 suppl 2:S208–12.

9. Zaman K, Sack DA, Neuzil KM, Yunus MD, Moulton LH, Sugimoto JD, et al. Effectiveness of a live oral human rotavirus vaccine after programmatic introduction in Bangladesh: A cluster-randomized trial. PLoS Med 14(4): e1002282. doi: 10.1371/journal.pmed.1002282 28419095

10. Zaman K, Anh DD, Victor JC, Shin S, Yunus M, Dallas MJ, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: A randomized, double-blind, placebo-controlled trial. Lancet. 2010;376:615–23. doi: 10.1016/S0140-6736(10)60755-6 20692031

11. Madhi S, Cunliffe NA, Steele AD, Witte D, Kirsten M, Louw C, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med. 2010;362:289–98. doi: 10.1056/NEJMoa0904797 20107214

12. Cunliffe NA, Witte D, Ngwira BM, Todd S, Bostock NJ, Turner AM, et al. Efficacy of human rotavirus vaccine against severe gastroenteritis in Malawian children in the first two years of life: A randomized, double-blind, placebo-controlled trial. Vaccine. 2012;30 suppl 1:A36–43.

13. Bhandari N, Rongsen-Chandola T, Bavdekar A, John J, Antony K, Taneja S, et al. Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: A randomized, double- blind, placebo-controlled trial. Lancet. 2014;383:2136–43. doi: 10.1016/S0140-6736(13)62630-6 24629994

14. Rheingans R, Anderson JD, Anderson B, Chakraborty P, Atherly D, Pindolia D. Estimated impact and cost effectiveness of rotavirus vaccination in India: Effects of geographic and economic disparities. Vaccine. 2014;32 suppl 1:A140–50.